Alzheimers disease is common, costly, and often mixed with other brain pathology The Alzheimers Association estimates that 7.4 million Americans age 65 and older are living with Alzheimers dementia in 2026
This reluctance may have several causes, including: The feeling that they are doing wellenough in managing their diabetes and do not want to make a change even if it may improve outcomes Concern that GI AEs may return Not wanting to change a routine that they see as working for them The change in device may be a barrier
compounded tirzepatide at $289/month versus $1,000+ for Zepbound
I mean that seriously because its never been the case that so many people are talking about the impact that they can have on weight loss, diabetes, insulin resistance, and appetite suppression
Smoothie King had already seen the writing on the wall, too, and created a menu section dedicated to GLP-1 Support. While previous consumer behavior studies have shown GLP-1s caused lower preference for high-fat foods and promoted weight loss, there has been limited information on how it influenced food preferences and consumption behavior across different food categories, McFadden said of a study he and collaborates recently published